ACB | Aurora Cannabis Inc.
9.04 -0.22 (-2.376%) Buy ACB
ACB Price Profile
NASDAQ/NGS (GLOBAL SELECT MARKET) Market ClosedMarket Cap.
$3.71 52 Week Low
What we like:
Full Extended Hours Trading
SIPC protected upto 500K
Trade Stocks, Options, ETFs & ADRs
Aurora Cannabis Inc. (ACB) Company Profile
Aurora Cannabis Inc. is a Canadian licensed cannabis producer with headquarters in Edmonton. Aurora was founded on December 21, 2006, by Terry Booth, Steve Dobler, Dale Lesack, and Chris Mayerson. The company went public on October 23, 2018, and it trades on the New York Stock Exchange (NYSE) under the ticker ACB.
Through its subsidiaries, Aurora Cannabis engages in the production and distribution of medical cannabis products worldwide. The company structure is vertically integrated and horizontally diversified across several segments of the cannabis value chain.
The chain includes facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. Furthermore, Aurora produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
It also sells vaporizers; consumable vaporizer accessories. The company engages in developing medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and the operation of CanvasRX.
Aurora Cannabis main competitors
- The Cronos Group
- CannTrust Holdings
- OrganiGram Holdings
Key Aurora Cannabis milestone
In January 2018, Aurora became the first private company to earn the rights to supply the Italian market through its German subsidiary Pedanios. According to the company, the first tender consisted of three lots of different cannabinoid profiles amounting to 100 kg.
In November 2019, Aurora opened an 11,000 square foot flagship retail center in West Edmonton Mall. The space is the largest retail outlet in Canada.
In March 2018, Aurora announced the completion of their acquisition of Cannimed, with both parties agreeing to the transaction based on friendly terms. With the agreement, Aurora’s total patient count to 42,000 registered cannabis patients in Canada.
Aurora Cannabis Frequently Asked Questions
Does Aurora Cannabis pay dividends?
Aurora Cannabis does not pay traditional dividends to investors.
Has Aurora split its stock?
Since going public, Aurora has split its stock once.
In which countries does Aurora cannabis operate?
Aurora Cannabis had eight licensed production facilities, five sales licenses, and operations in 25 countries.